{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:17:42Z","timestamp":1792898262704,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23fk0108673"],"award-info":[{"award-number":["JP23fk0108673"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23gm1610013"],"award-info":[{"award-number":["JP23gm1610013"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24jm0210111"],"award-info":[{"award-number":["JP24jm0210111"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.rmed.2025.108408","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:47:53Z","timestamp":1760060873000},"page":"108408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Real-world effectiveness and lung abnormalities associated with amikacin liposome inhalation suspension"],"prefix":"10.1016","volume":"248","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3194-0890","authenticated-orcid":false,"given":"Nozomi","family":"Tokita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9498-6995","authenticated-orcid":false,"given":"Masashi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4018-5364","authenticated-orcid":false,"given":"Naohisa","family":"Urabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1139-1604","authenticated-orcid":false,"given":"Keiji","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1208-7698","authenticated-orcid":false,"given":"Koji","family":"Furuuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6747-2390","authenticated-orcid":false,"given":"Yoshiaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7278-8816","authenticated-orcid":false,"given":"Takashi","family":"Yoshiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6801-0147","authenticated-orcid":false,"given":"Kazuma","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8239-9275","authenticated-orcid":false,"given":"Kozo","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rmed.2025.108408_bib1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ccm.2023.08.012","article-title":"Global epidemiology of nontuberculous mycobacterial pulmonary disease: a review","volume":"44","author":"Prevots","year":"2023","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.rmed.2025.108408_bib2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijid.2022.10.013","article-title":"Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review","volume":"125","author":"Dahl","year":"2022","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.rmed.2025.108408_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.rmed.2025.108408_bib4","doi-asserted-by":"crossref","first-page":"ofaf118","DOI":"10.1093\/ofid\/ofaf118","article-title":"Effects of amikacin liposome inhalation suspension and amikacin resistance development in patients with refractory Mycobacterium avium complex pulmonary disease","volume":"12","author":"Kurahara","year":"2025","journal-title":"Open Forum Infect. Dis."},{"issue":"3","key":"10.1016\/j.rmed.2025.108408_bib5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.chest.2021.03.070","article-title":"Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex lung disease: sustainability and durability of culture conversion and safety of long-term exposure","volume":"160","author":"Griffith","year":"2021","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2025.108408_bib6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.resinv.2023.12.012","article-title":"Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: a subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT study","volume":"62","author":"Morimoto","year":"2024","journal-title":"Respir. Investig."},{"issue":"16","key":"10.1016\/j.rmed.2025.108408_bib7","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.2169\/internalmedicine.8796-21","article-title":"Liposomal amikacin inhalation suspension-induced pneumonitis","volume":"61","author":"Kidogawa","year":"2022","journal-title":"Intern. Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108408_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.resinv.2024.04.003","article-title":"Drug-related pneumonitis caused by amikacin liposome inhalation suspension: one pathologically proven case and single-center experience","volume":"62","author":"Kaneko","year":"2024","journal-title":"Respir. Investig."},{"issue":"8","key":"10.1016\/j.rmed.2025.108408_bib9","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jiac.2023.04.013","article-title":"A case of drug-induced organizing pneumonia caused by amikacin liposome inhalation suspension","volume":"29","author":"Takao","year":"2023","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.rmed.2025.108408_bib10","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.2147\/IDR.S427544","article-title":"Diagnosis and management of drug-induced interstitial lung disease associated with amikacin liposome inhalation suspension in refractory Mycobacterium avium complex pulmonary disease: a case report","volume":"16","author":"Hashimoto","year":"2023","journal-title":"Infect. Drug Resist."},{"issue":"1","key":"10.1016\/j.rmed.2025.108408_bib11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s12890-024-03261-w","article-title":"Effectiveness of Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex pulmonary disease at 6 months post initiation","volume":"24","author":"Urabe","year":"2024","journal-title":"BMC Pulm. Med."},{"issue":"12","key":"10.1016\/j.rmed.2025.108408_bib12","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","article-title":"Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT). A prospective, open-label, randomized study","volume":"198","author":"Griffith","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108408_bib13","series-title":"CLSI Standards: Guidelines for Health Care Excellence, Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes","author":"Woods","year":"2011"},{"issue":"7","key":"10.1016\/j.rmed.2025.108408_bib14","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/cid\/cix517","article-title":"Treatment outcomes of Mycobacterium avium complex lung disease: a systematic review and meta-analysis","volume":"65","author":"Kwak","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.rmed.2025.108408_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2169\/internalmedicine.53.1277","article-title":"Nutritional indicators are correlated with the radiological severity score in patients with Mycobacterium avium complex pulmonary disease: a cross-sectional study","volume":"53","author":"Morimoto","year":"2014","journal-title":"Intern. Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108408_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"10.1016\/j.rmed.2025.108408_bib17","doi-asserted-by":"crossref","first-page":"872","DOI":"10.5588\/ijtld.23.0275","article-title":"Management of dysphonia caused by amikacin liposome inhalation in M. avium complex pulmonary disease","volume":"27","author":"Kurahara","year":"2023","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"4","key":"10.1016\/j.rmed.2025.108408_bib18","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1183\/23120541.01084-2024","article-title":"Risk factors, molecular analysis and treatment outcomes of amikacin-resistant Mycobacterium avium complex pulmonary disease","volume":"11","author":"Kodama","year":"2025","journal-title":"ERJ Open Res."},{"issue":"2","key":"10.1016\/j.rmed.2025.108408_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5350","article-title":"Laryngitis after inhalation of liposomal amikacin","volume":"10","author":"Morita","year":"2022","journal-title":"Clin. Case Rep."},{"issue":"4","key":"10.1016\/j.rmed.2025.108408_bib20","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/j.chest.2020.11.045","article-title":"Laryngeal injury due to amikacin inhalation for refractory Mycobacterium avium complex infection","volume":"159","author":"Axiotakis","year":"2021","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2025.108408_bib21","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults. An official ATS\/JRS\/ALAT clinical practice guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108408_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1390083","article-title":"Regional diversity in drug-induced lung diseases among the USA, European Union, and Japan","volume":"11","author":"Sato","year":"2024","journal-title":"Front. Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125004718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125004718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:28:11Z","timestamp":1777595291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125004718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":22,"alternative-id":["S0954611125004718"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108408","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6033395\/v1","asserted-by":"object"}]},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world effectiveness and lung abnormalities associated with amikacin liposome inhalation suspension","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108408"}}